Skip to main content
Tag

Gleason grading

9 entries all tags

Sep 6, 2026
General discussion 2022 thesis · Ch. 6 A look back at the four studies and forward: how AI support fits a pathologist's workflow, and what diagnostics could look like beyond Gleason grading.
Sep 5, 2026
AI-assisted Gleason grading 2022 thesis · Ch. 5 Fourteen pathologists graded 160 biopsies with and without AI assistance. With the AI they agreed more with the expert reference, and beat the standalone system.
Sep 3, 2026
The PANDA Challenge 2022 thesis · Ch. 4 A global competition on 10,616 public biopsies drew 1,290 developers. The resulting algorithms matched pathologist-level grading on blinded US and EU cohorts.
Sep 2, 2026
Automated Gleason grading of prostate biopsies 2022 thesis · Ch. 3 We built a deep-learning system that grades prostate biopsies without manual annotations. It matched the expert consensus and outperformed 10 of 15 pathologists.
Aug 30, 2026
General introduction 2022 thesis · Ch. 1 How prostate cancer is diagnosed and graded, why Gleason grading varies so much between pathologists, and what deep learning brings to the problem.
Jan 13, 2022
AI for diagnosis of prostate cancer: the PANDA challenge Artificial intelligence (AI) for prostate cancer analysis is ready for clinical implementation, shows a global programming competition, the PANDA challenge.
Apr 9, 2020
Improve prostate cancer diagnosis: participate in the PANDA Gleason grading challenge Can you build a deep learning model that can accurately grade prostate biopsies? Participate in the PANDA challenge
Feb 25, 2020
The potential of AI in medicine: AI-assistance improves prostate cancer grading In a completely new study we investigated the possible benefits of an AI system for pathologists. Instead of focussing on pathologist-versus-AI, we instead look at potential pathologist-AI synergy.
Jul 23, 2019
Pathologist-level Gleason grading using artificial intelligence (AI) & deep learning We developed a fully automated deep learning system to grade prostate biopsies using 5759 biopsies from 1243 patients, and showed that this system achieved pathologist-level performance.

Copyright © 2026 Wouter Bulten

I may not have gone where I intended to go, but I think I have ended up where I needed to be.

Douglas Adams, The Long Dark Tea-Time of the Soul